Dirk Spitzer

2.2k total citations
38 papers, 1.4k citations indexed

About

Dirk Spitzer is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Dirk Spitzer has authored 38 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 12 papers in Immunology and 7 papers in Oncology. Recurrent topics in Dirk Spitzer's work include Pharmacological Receptor Mechanisms and Effects (15 papers), Cancer therapeutics and mechanisms (11 papers) and Virus-based gene therapy research (6 papers). Dirk Spitzer is often cited by papers focused on Pharmacological Receptor Mechanisms and Effects (15 papers), Cancer therapeutics and mechanisms (11 papers) and Virus-based gene therapy research (6 papers). Dirk Spitzer collaborates with scholars based in United States, Italy and United Kingdom. Dirk Spitzer's co-authors include William G. Hawkins, John P. Atkinson, Dennis E. Hourcade, Lynne M. Mitchell, Robert H. Mach, Suwanna Vangveravong, John R. Hornick, Peter S. Goedegebuure, John Atkinson and Jinbin Xu and has published in prestigious journals such as Nature Communications, Blood and The Journal of Immunology.

In The Last Decade

Dirk Spitzer

38 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk Spitzer United States 20 868 351 180 162 151 38 1.4k
Clark Q. Pan United States 23 1.0k 1.2× 227 0.6× 181 1.0× 179 1.1× 172 1.1× 47 1.9k
Axel Choidas Germany 16 1.4k 1.6× 586 1.7× 176 1.0× 64 0.4× 87 0.6× 30 2.0k
Kohji Kasahara Japan 22 1.1k 1.2× 173 0.5× 97 0.5× 210 1.3× 72 0.5× 60 1.6k
Zining Wu United States 22 735 0.8× 320 0.9× 82 0.5× 42 0.3× 102 0.7× 60 1.4k
Samuel G. Katz United States 22 1.6k 1.9× 354 1.0× 62 0.3× 171 1.1× 82 0.5× 53 2.2k
Michael J. Orsini United States 17 1.0k 1.2× 552 1.6× 358 2.0× 88 0.5× 110 0.7× 27 1.9k
Nozomi Yamaguchi Japan 27 905 1.0× 262 0.7× 139 0.8× 300 1.9× 109 0.7× 71 2.2k
Frédéric Lopez France 25 1.3k 1.5× 603 1.7× 115 0.6× 116 0.7× 54 0.4× 46 2.6k
Daniela Bumbaca United States 20 1.0k 1.2× 359 1.0× 86 0.5× 84 0.5× 52 0.3× 29 2.2k
Scott P. Kennedy United States 20 847 1.0× 285 0.8× 191 1.1× 35 0.2× 91 0.6× 27 1.6k

Countries citing papers authored by Dirk Spitzer

Since Specialization
Citations

This map shows the geographic impact of Dirk Spitzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk Spitzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk Spitzer more than expected).

Fields of papers citing papers by Dirk Spitzer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk Spitzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk Spitzer. The network helps show where Dirk Spitzer may publish in the future.

Co-authorship network of co-authors of Dirk Spitzer

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk Spitzer. A scholar is included among the top collaborators of Dirk Spitzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk Spitzer. Dirk Spitzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vangveravong, Suwanna, Qingqing Gong, S. Peter Goedegebuure, et al.. (2024). The novel drug candidate S2/IAPinh improves survival in models of pancreatic and ovarian cancer. Scientific Reports. 14(1). 6373–6373. 1 indexed citations
2.
Prudner, Bethany C., Richa Rathore, Katharine E. Caldwell, et al.. (2022). Malic Enzyme 1 Absence in Synovial Sarcoma Shifts Antioxidant System Dependence and Increases Sensitivity to Ferroptosis Induction with ACXT-3102. Clinical Cancer Research. 28(16). 3573–3589. 19 indexed citations
3.
Binder, Pratibha, Yassar M. Hashim, Suwanna Vangveravong, et al.. (2022). The targeted SMAC mimetic SW IV-134 augments platinum-based chemotherapy in pre-clinical models of ovarian cancer. BMC Cancer. 22(1). 263–263. 2 indexed citations
4.
Mpoy, Cedric, Jalen Scott, Truc T. Huynh, et al.. (2020). Preclinical Evaluation of an Engineered Single-Chain Fragment Variable-Fragment Crystallizable Targeting Human CD44. Journal of Nuclear Medicine. 62(1). 137–143. 15 indexed citations
5.
6.
7.
Hashim, Yassar M., Dirk Spitzer, Suwanna Vangveravong, et al.. (2014). Targeted pancreatic cancer therapy with the small molecule drug conjugate SW IV‐134. Molecular Oncology. 8(5). 956–967. 34 indexed citations
8.
Hornick, John R., Suwanna Vangveravong, Dirk Spitzer, et al.. (2012). Lysosomal Membrane Permeabilization is an Early Event in Sigma-2 Receptor Ligand Mediated Cell Death in Pancreatic Cancer. Journal of Experimental & Clinical Cancer Research. 31(1). 41–41. 65 indexed citations
9.
Spitzer, Dirk, Peter O. Simon, Hiroyuki Kashiwagi, et al.. (2011). Use of Multifunctional Sigma-2 Receptor Ligand Conjugates to Trigger Cancer-Selective Cell Death Signaling. Cancer Research. 72(1). 201–209. 43 indexed citations
10.
Xu, Jinbin, Chenbo Zeng, Wenhua Chu, et al.. (2011). Identification of the PGRMC1 protein complex as the putative sigma-2 receptor binding site. Nature Communications. 2(1). 380–380. 270 indexed citations
11.
Spitzer, Dirk, Jonathan E. McDunn, Stacey M. Plambeck-Suess, et al.. (2010). A Genetically Encoded Multifunctional TRAIL Trimer Facilitates Cell-Specific Targeting and Tumor Cell Killing. Molecular Cancer Therapeutics. 9(7). 2142–2151. 14 indexed citations
12.
Зайцев, С. В., Dirk Spitzer, Juan-Carlos Murciano, et al.. (2010). Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation. Blood. 115(25). 5241–5248. 87 indexed citations
13.
Зайцев, С. В., Dirk Spitzer, Juan-Carlos Murciano, et al.. (2009). Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis. Journal of Pharmacology and Experimental Therapeutics. 332(3). 1022–1031. 57 indexed citations
14.
Wu, Xiaobo, Dirk Spitzer, Dailing Mao, et al.. (2008). Membrane Protein Crry Maintains Homeostasis of the Complement System. The Journal of Immunology. 181(4). 2732–2740. 25 indexed citations
15.
Spitzer, Dirk, Lynne M. Mitchell, John P. Atkinson, & Dennis E. Hourcade. (2007). Properdin Can Initiate Complement Activation by Binding Specific Target Surfaces and Providing a Platform for De Novo Convertase Assembly. The Journal of Immunology. 179(4). 2600–2608. 210 indexed citations
16.
Kavanagh, David, Dirk Spitzer, Anna Richards, et al.. (2007). The decay accelerating factor mutation I197V found in hemolytic uraemic syndrome does not impair complement regulation. Molecular Immunology. 44(12). 3162–3167. 19 indexed citations
17.
Spitzer, Dirk, Xiaobo Wu, Xiucui Ma, et al.. (2006). Cutting Edge: Treatment of Complement Regulatory Protein Deficiency by Retroviral In Vivo Gene Therapy. The Journal of Immunology. 177(8). 4953–4956. 10 indexed citations
18.
Spitzer, Dirk, Jacqueline Unsinger, Dailing Mao, et al.. (2005). In Vivo Correction of Complement Regulatory Protein Deficiency with an Inhibitor Targeting the Red Blood Cell Membrane. The Journal of Immunology. 175(11). 7763–7770. 20 indexed citations
19.
Gill, Darcy B., Dirk Spitzer, Michael Koomey, John E. Heuser, & John P. Atkinson. (2005). Release of host-derived membrane vesicles following pilus-mediated adhesion of Neisseria gonorrhoeae. Cellular Microbiology. 7(11). 1672–1683. 16 indexed citations
20.
Häuser, H., Dirk Spitzer, Els Verhoeyen, Jacqueline Unsinger, & Dagmar Wirth. (2000). New Approaches towards ex vivo and in vivo Gene Therapy. Cells Tissues Organs. 167(2-3). 75–80. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Clark Q. Pan Breakdown of academic impact, for papers by Axel Choidas Breakdown of academic impact, for papers by Kohji Kasahara Breakdown of academic impact, for papers by Zining Wu Breakdown of academic impact, for papers by Samuel G. Katz Breakdown of academic impact, for papers by Michael J. Orsini Breakdown of academic impact, for papers by Nozomi Yamaguchi Breakdown of academic impact, for papers by Frédéric Lopez Breakdown of academic impact, for papers by Daniela Bumbaca Breakdown of academic impact, for papers by Scott P. Kennedy
Rankless by CCL
2026